Prevention of infectious complications after genital prolapse surgery

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: To improve the outcomes of correction of genital prolapse by modifying the colporrhaphy technique and prescribing Epigen Intim spray as an anti-inflammatory and regenerating agent in the postoperative period.

Materials and methods: The study included 60 perimenopausal patients with signs of POP-Q stage 2 or higher cystocele/rectocele. The traditional colporrhaphy technique was used in group 1, and subfascial dissection of tissues was performed in group 2. After discharge from the hospital, the postoperative stage of patients in group 2 was modified: they used Epigen Intim spray for a prolonged period of time, twice a day for 45 days.

Results: In 45 days after the treatment, the signs of complications in the form of hematoma, compaction and edema in the area of postoperative sutures were noted in 10% of cases among the patients of group 1; there were complaints of pelvic pain in three cases in group 1, and only in one case in group 2 (3.3%). The analysis of the vaginal microbiome using PCR showed that the ratio of normoflora/opportunistic microorganisms had a more favorable profile in group 2 (Lactobacillus spp. – 106.5 (68.6%) in group 1, 107.2 (78.3%) in group 2). Moreover, various dynamics of Veillonella spp. and Gardnerella vaginalis concentrations was revealed (102.6 in patients with complications versus 100.7 in uncomplicated patients; 105.1 versus 102.7 in group 1 and 102.4 in group 2).

Conclusion: The surgical correction of genital prolapse requires an efficient approach; therefore, it is necessary to apply the optimal technique of colporrhaphy due to subfascial dissection of tissues and choose the proper postoperative tactics. The use of special medications, such as Epigen Intim spray with anti-inflammatory and regenerating effects after subfascial colporrhaphy allows patients to adapt the state of the vaginal microbiome and accelerate tissue regeneration, which can reduce the risk of complications.

Full Text

Restricted Access

About the authors

Yulia E. Dobrokhotova

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: Pr.Dobrohotova@mail.ru
ORCID iD: 0000-0002-7830-2290

Dr. Med. Sci., Professor, Head of the Department of Obstetrics and Gynaecology

Russian Federation, Moscow

Irina A. Lapina

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Author for correspondence.
Email: doclapina@mail.ru
ORCID iD: 0000-0002-2875-6307

Dr. Med. Sci., Proferssor, Department of Obstetrics and Gynaecology

Russian Federation, Moscow

Anatoly G. Tyan

Group of companies MEDSI

Email: doctortyan@yandex.ru
ORCID iD: 0000-0003-1659-4256

PhD, GK MEDSI

Russian Federation, Moscow

Vladislav V. Taranov

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: vlastaranov@mail.ru
ORCID iD: 0000-0003-2338-2884

PhD., Assistant of the Department of Obstetrics and Gynaecology

Russian Federation, Moscow

Tatiana G. Chirvon

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: tkoltinova@gmail.com
ORCID iD: 0000-0002-8302-7510

PhD, Assistant of the Department of Obstetrics and Gynaecology

Russian Federation, Moscow

Nikita V. Glebov

Group of companies MEDSI

Email: glebov.nv@medsigroup.ru
ORCID iD: 0000-0002-7072-6953

Doctor of Gynecological Department

Russian Federation, Moscow

Olesya V. Kaykova

Group of companies MEDSI

Email: kajkova.ov@medsigroup.ru

Head of Gynecological Department

Russian Federation, Moscow

References

  1. Noé G.K. Genital prolapse surgery: what options do we have in the age of mesh issues? J Clin. Med. 2021; 10(2): 267. https://dx.doi.org/10.3390/ jcm10020267.
  2. Maher C., Yeung E., Haya N., Christmann-Schmid C., Mowat A., Chen Z. et al. Surgery for women with apical vaginal prolapse. Cochrane Database Syst. Rev. 2023; 7(7): CD012376. https://dx.doi.org/10.1002/ 14651858.CD012376.pub2.
  3. Glazener C., Breeman S., Elders A., Hemming C., Cooper K.G., Freeman R.M. et al.; PROSPECT Study Group. Mesh inlay, mesh kit or native tissue repair for women having repeat anterior or posterior prolapse surgery: randomised controlled trial (PROSPECT). BJOG. 2020; 127(8): 1002-13. https://dx.doi.org/10.1111/1471-0528.16197.
  4. Baessler K., Christmann-Schmid C., Maher C., Haya N., Crawford T.J., Brown J. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst. Rev. 2018; 8(8): CD013108. https://dx.doi.org/10.1002/14651858.CD013108.
  5. Horosz E., Pomian A., Zwierzchowska A., Majkusiak W., Tomasik P., Barcz E. Does previous pelvic organ prolapse surgery influence the effectiveness of the sub-urethral sling procedure? J. Clin. Med. 2020; 9(3): 653. https://dx.doi.org/ 10.3390/jcm9030653.
  6. Digesu G.A., Bhide A.A., Swift S. Mid-urethral sling and the mystery of pain. Int. Urogynecol. J. 2022; 33(4): 749-50. https://dx.doi.org/10.1007/ s00192-022-05192-8.
  7. Lundmark Drca A., Alexandridis V., Andrada Hamer M., Teleman P., Söderberg M.W., Ek M. Dyspareunia and pelvic pain: comparison of mid-urethral sling methods 10 years after insertion. Int. Urogynecol. J. 2024; 35(1): 43-50. https://dx.doi.org/10.1007/s00192-023-05585-3.
  8. Rovner E., de Tayrac R., Kirschner-Hermanns R., Veit-Rubin N., Anding R. Is polypropylene mesh material fundamentally safe for use as a reconstructive material in vaginal surgery: ICI-RS 2019? Neurourol. Urodyn. 2020; 39 Suppl 3: S132-S139. https://dx.doi.org/10.1002/nau.24312.
  9. Hermieu N., Ouzaid I., Aoun R., Xylinas E., Hermieu J.F., Schoentgen N. Urethral exposure of mid-urethral sling: diagnosis, management and functional outcomes. Urology. 2022; 164: 100-5. https://dx.doi.org/10.1016/j.urology.2022.01.016.
  10. Ерема В.В., Буянова С.Н., Мгелиашвили М.В., Ерема В.В., Петракова С.А. Mesh-ассоциированные осложнения при коррекции пролапса тазовых органов и стрессовой формы недержания мочи. Российский вестник акушера-гинеколога. 2021; 21(3): 74-78. [Erema V.V., Buyanova S.N., Mgeliashvili M.V., Petrakova S.A., Puchkova N.V., Yudina N.V., Glebov T.A. Mesh-associated complications in the correction of pelvic organ prolapse and stress urinary incontinence. Russian Bulletin of Obstetrician-Gynecologist. 2021; 21(3): 74-8. (in Russian)]. https://dx.doi.org/10.17116/rosakush20212103174.
  11. Deffieux X., Letouzey V., Savary D., Sentilhes L., Agostini A., Mares P., Pierre F.; French College of Obstetrics and Gynecology (CNGOF). Prevention of complications related to the use of prosthetic meshes in prolapse surgery: guidelines for clinical practice. Eur. J. Obstet. Gynecol. Reprod. Biol. 2012; 165(2): 170-80. https://dx.doi.org/10.1016/ j.ejogrb.2012.09.001.
  12. Daly J.O., Frazer M., Cartwright R., Veit-Rubin N., Giles M. The role of microbial colonisation and infection in pelvic floor mesh complications and implications for management: a commentary. BJOG. 2020; 127(2): 260-3. https://dx.doi.org/10.1111/1471-0528.15965.
  13. Fettweis J.M., Serrano M.G., Girerd P.H., Jefferson K.K., Buck G.A. A new era of the vaginal microbiome: advances using next-generation sequencing. Chem. Biodivers. 2012; 9(5): 965-76. https://dx.doi.org/10.1002/cbdv.201100359.
  14. Veit-Rubin N., De Tayrac R., Cartwright R., Franklin-Revill L., Warembourg S., Dunyach-Remy C. et al. Abnormal vaginal microbiome associated with vaginal mesh complications. Neurourol. Urodyn. 2019; 38(8): 2255-63. https://dx.doi.org/10.1002/nau.24129.
  15. Hawn M.T., Richman J.S., Vick C.C., Deierhoi R.J., Graham L.A., Henderson W.G. et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg. 2013; 148(7): 649-57. https://dx.doi.org/10.1001/jamasurg.2013.134.
  16. Попов А.А., Идашкин А.Д., Тюрина С.С., Будыкина Т.С. Возможности использования программы ускоренного восстановления в коррекции течения послеоперационного периода при хирургическом лечении в гинекологии. Российский вестник акушера-гинеколога. 2019; 19(6): 23-30. [Popov A.A., Idashkin A.D., Tiurina S.S., Budykina T.S. Possibilities of using a fast track recovery program to correct a postoperative course after surgical treatment in gynekology. Russian Bulletin of Obstetrician-Gynecologist. 2019; 19(6): 23-30. (in Russian)]. https://dx.doi.org/10.17116/rosakush20191906123.
  17. Попов А.А., Федоров А.А., Идашкин А.Д., Тюрина С.С., Коваль А.А., Головин А.А., Упрямова Е.Ю., Ефремова Е.С., Краснопольская И.В. Реализация программы ускоренного восстановления у пациенток, оперированных лапароскопическим и робот-ассистированным доступом в гинекологии. Информационно-методическое письмо. Москва: МАКС Пресс; 2021. 24 c. [Popov A.A., Fedorov A.A., Idashkin A.D., Tyurina S.S., Koval A.A., Golovin A.A., Upryamova E.Yu., Efremova E.S., Krasnopolskaya I.V. Implementation of the accelerated recovery program in patients operated on laparoscopic and robot-assisted access in gynecology. Information and methodological letter. Moscow: MAKS Press; 2021. 24 p. (in Russian)].
  18. Шуршалина А.В., Кречетова Л.В., Зиганшина М.М., Сухих Г.Т. Локальное действие Эпиген Интим спрей (глицирризиновая кислота) при вирусных инфекциях половых органов. Акушерство и гинекология. 2009; 3: 63-5. [Shurshalina A.V., Krechetova L.V., Ziganshina M.M., Sukhikh G.T. Local action of glycyrrhizic acid in genital viral infections. Obstetrics and Gynecology. 2009; 3: 63-5.(in Russian)].
  19. Рахматулина М.Р., Большенко Н.В. Опыт применения активированной глицирризиновой кислоты при вульвовагинитах, цервицитах и генитальной папилломавирусной инфекции. Акушерство и гинекология. 2019; 9: 153-158. [Rakhmatulina M.R., Bolshenko N.V., Lipova E.V. Experience of application of activated glycyrrhizic acid.in vulvovaginitis, cervicitis, and genital papillomavirus infection. Obstetrics and Gynecology. 2019; (9): 153-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.9.153-158.
  20. Шкарупа Д.Д., Кубин Н.Д., Шаповалова Е.А., Зайцева А.О., Писарев А.В. Комбинированная реконструкция тазового дна при дефектах I и II уровней поддержки: задний интравагинальный слинг и субфасциальная кольпоррафия. Акушерство и гинекология. 2016; 8: 99-105. [Shkarupa D.D., Kubin N.D., Shapovalova E.A., Zaitseva A.O., Pisarev A.V. Combined pelvic floor repair in Levels I and II support defects: Posterior intravaginal sling and subfascial colporrhaphy. Obstetrics and Gynecology. 2016; (8): 99-105. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.8.99-105.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Study design (n=60)

Download (16KB)
3. Fig. 2. Staging of genital prolapse based on POP-Q classification, n=60

Download (14KB)
4. Fig. 3. Characteristics of complaints among patients of both groups, n=60

Download (22KB)

Copyright (c) 2024 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies